GEM Gene
Overview
GEM (GTP-binding protein, mitotic spindle positioning, also known as Gem) is a member of the Rad/Gem/Kir family of small GTP-binding proteins. GEM is a unique GTPase that is predominantly expressed in neuronal and cardiac tissues, where it plays critical roles in regulating calcium channel activity, synaptic plasticity, neuronal excitability, and microtubule dynamics. Originally identified as a gene induced by mitogenic stimulation, GEM has emerged as a key regulator of neuronal signaling pathways with significant implications for neurodegenerative diseases, epilepsy, and neurodevelopmental disorders. [@maguire1994, @katagiri2000]
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | GEM |
| Gene Name | GTP-Binding Protein GEM |
| Aliases | Kir, Rad, Gem, GTP-binding protein associated with rough endoplasmic reticulum |
| Chromosomal Location | 8q22.1 |
| NCBI Gene ID | [2664](https://www.ncbi.nlm.nih.gov/gene/2664) |
| OMIM | [605394](https://www.omim.org/entry/605394) |
| UniProt | [P55042](https://www.uniprot.org/uniprot/P55042) |
| Ensembl | [ENSG00000164946](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164946) |
| Protein Class | Small GTPase (Rad/Gem/Kir family) |
| Expression | Brain (cortex, hippocampus, cerebellum), heart, skeletal muscle |
</div>
Protein Structure and Function
Structural Features
GEM is a member of the Ras superfamily of small GTPases, but with unique structural features:
...GEM Gene
Overview
GEM (GTP-binding protein, mitotic spindle positioning, also known as Gem) is a member of the Rad/Gem/Kir family of small GTP-binding proteins. GEM is a unique GTPase that is predominantly expressed in neuronal and cardiac tissues, where it plays critical roles in regulating calcium channel activity, synaptic plasticity, neuronal excitability, and microtubule dynamics. Originally identified as a gene induced by mitogenic stimulation, GEM has emerged as a key regulator of neuronal signaling pathways with significant implications for neurodegenerative diseases, epilepsy, and neurodevelopmental disorders. [@maguire1994, @katagiri2000]
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | GEM |
| Gene Name | GTP-Binding Protein GEM |
| Aliases | Kir, Rad, Gem, GTP-binding protein associated with rough endoplasmic reticulum |
| Chromosomal Location | 8q22.1 |
| NCBI Gene ID | [2664](https://www.ncbi.nlm.nih.gov/gene/2664) |
| OMIM | [605394](https://www.omim.org/entry/605394) |
| UniProt | [P55042](https://www.uniprot.org/uniprot/P55042) |
| Ensembl | [ENSG00000164946](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164946) |
| Protein Class | Small GTPase (Rad/Gem/Kir family) |
| Expression | Brain (cortex, hippocampus, cerebellum), heart, skeletal muscle |
</div>
Protein Structure and Function
Structural Features
GEM is a member of the Ras superfamily of small GTPases, but with unique structural features:
GTP-binding domains:
- GXXXXGKST (P-loop) motif for nucleotide binding
- Switch I region (residues 32-40): Conformational changes upon GTP/GDP binding
- Switch II region (residues 58-67): Critical for effector interactions
- C-terminal hypervariable region: Determines specific protein interactions
Unique properties:
- Rapid GDP/GTP exchange without requiring guanine nucleotide exchange factors (GEFs)
- Intrinsic GTP hydrolysis activity (slower than other GTPases)
- Calcium-binding EF-hand domains (unique among small GTPases)
- C-terminal prenylation site for membrane localization
GTPase Cycle
GEM, unlike classical GTPases, has distinctive nucleotide binding properties:
GTP-bound state (active):
- Binds GTP with high affinity
- Interacts with downstream effectors
- Regulates ion channel activity
- Modulates cytoskeletal dynamics
GDP-bound state (inactive):
- Does not require GEFs for activation
- Can be rapidly converted to GTP-bound form
- May have distinct cellular functions
Nucleotide exchange mechanism:
- Spontaneous nucleotide exchange (no GEF required)
- Calcium-dependent activation
- Phosphorylation-mediated regulation
Calcium Channel Regulation
One of the most important functions of GEM is its regulation of calcium channels:
N-type calcium channels (Cav2.2):
- GEM directly binds to the α1B subunit
- Inhibits channel gating and current amplitude
- Modulates presynaptic calcium influx
- Regulates neurotransmitter release
L-type calcium channels (Cav1.2):
- GEM associates with the α1C subunit
- Alters voltage dependence of activation
- Affects calcium-dependent gene expression
P/Q-type calcium channels (Cav2.1):
- Modulation of channel trafficking
- Regulation of synaptic vesicle release
This calcium channel regulation is critical for synaptic transmission and neuronal excitability. [@beguin2001, @wang2002]
Physiological Roles
Synaptic Plasticity
GEM plays a crucial role in synaptic plasticity mechanisms:
Long-term potentiation (LTP):
- GEM is recruited to postsynaptic densities during LTP
- Modulates NMDA receptor function through interactions with scaffolding proteins
- Regulates AMPA receptor trafficking and insertion
- Contributes to the maintenance of LTP
Long-term depression (LTD):
- GEM affects the internalization of AMPA receptors during LTD
- Regulates protein phosphatase activity
- Modifies dendritic spine morphology
Calcium signaling: GEM interacts with calcium-dependent signaling pathways:
- Calmodulin-dependent protein kinases
- Calcineurin (protein phosphatase 2B)
- Calcium/calmodulin-dependent protein kinases (CaMKII)
[@tommasini2013, @yang2015]
Neuronal Excitability
GEM regulates neuronal excitability through multiple mechanisms:
Potassium channel modulation:
- Modulates delayed rectifier potassium currents
- Affects neuronal firing patterns
- Contributes to action potential repolarization
Resting membrane potential:
- Regulates ion channel activity at rest
- Maintains neuronal membrane potential
Epilepsy susceptibility:
- Altered GEM expression is associated with epileptogenesis
- GEM dysfunction leads to hyperexcitability
- Contributes to seizure generation and propagation
[@yao2021]
Microtubule Dynamics
GEM interacts with the cytoskeleton:
Microtubule organization:
- Binds to tubulin and microtubules
- Promotes microtubule stability
- Affects intracellular transport
- Regulates neuronal process extension
Axonal transport:
- Modulates vesicle transport along microtubules
- Affects organelle trafficking
- Regulates synaptic protein delivery
[@yun1998]
Neuronal Survival and Death
GEM regulates neuronal viability:
Pro-survival functions:
- Promotes neuronal survival under stress conditions
- Interacts with anti-apoptotic pathways
- Modulates cellular energy metabolism
Disease contexts:
- Altered GEM expression in neurodegenerative diseases
- GEM dysregulation contributes to neuronal loss
- Potential therapeutic target for neuroprotection
[@le2005]
Expression Pattern
Tissue Distribution
GEM exhibits tissue-specific expression:
- Brain: Highest expression in cortex, hippocampus, cerebellum
- Heart: Significant expression in cardiac myocytes
- Skeletal muscle: Moderate expression
- Kidney, lung: Lower expression
Brain Regional Expression
Within the brain:
- Cerebral cortex: Pyramidal neurons, interneurons
- Hippocampus: CA1-CA3 pyramidal cells, dentate gyrus granule cells
- Cerebellum: Purkinje cells, granule cells
- Thalamus: Various thalamic nuclei
- Brainstem: Motor and sensory nuclei
Cellular Localization
In neurons, GEM is found in:
- Dendritic spines (postsynaptic)
- Axon terminals (presynaptic)
- Somatic cytoplasm
- Proximal dendrites
- Synaptic vesicles
Disease Associations
Epilepsy
GEM has a well-established role in epilepsy:
Expression changes: GEM expression is altered in epileptic tissue:
- Upregulation in seizure foci
- Changes in subcellular distribution
- Altered post-translational modifications
Mechanisms:
- Dysregulated calcium channel modulation
- Increased neuronal excitability
- Enhanced excitatory synaptic transmission
- Impaired inhibitory signaling
Therapeutic implications:
- GEM-targeted therapies for seizure control
- Gene therapy approaches
- Small molecule modulators
[@yao2021]
Alzheimer's Disease
GEM is implicated in Alzheimer's disease pathogenesis:
Expression alterations: Changes in GEM in AD brain:
- Altered expression in affected brain regions
- Dysregulated calcium homeostasis
- Effects on amyloid processing
Pathogenic mechanisms:
- Calcium dysregulation: GEM dysregulation contributes to calcium dysregulation in AD
- Synaptic dysfunction: Altered GEM affects synaptic plasticity
- Tau pathology: Interactions with tau phosphorylation pathways
Therapeutic potential:
- Targeting GEM for neuroprotection
- Modulating calcium signaling
[@chen2018]
Parkinson's Disease
Emerging evidence links GEM to Parkinson's disease:
Dopaminergic neurons:
- GEM is expressed in dopaminergic neurons of substantia nigra
- Regulation of calcium homeostasis in these neurons
- Vulnerability to degeneration
Mechanisms:
- Mitochondrial function: GEM affects mitochondrial calcium handling
- Oxidative stress: Altered GEM expression in PD models
- α-Synuclein interaction: Potential functional connections
[@liu2020]
Other Neurological Disorders
Amyotrophic lateral sclerosis (ALS):
- GEM expression changes in motor neurons
- Potential role in excitotoxicity
- Implications for disease progression
Huntington's disease:
- Altered GEM in Huntington's disease models
- Potential modulation of excitotoxicity
Migraine:
- GEM variants associated with familial hemiplegic migraine
- Calcium channel regulation in vascular smooth muscle
Cardiovascular Disease
While primarily studied in neurons, GEM also has cardiovascular relevance:
Cardiac function:
- Expression in cardiac myocytes
- Regulation of calcium handling
- Potential role in cardiac hypertrophy
Therapeutic Implications
Drug Development
Targeting GEM for neurological therapies:
Small molecule modulators:
- GEM activators to enhance neuroprotective functions
- GEM inhibitors for hyperexcitability conditions
- Calcium channel interaction modulators
Peptide-based approaches:
- Interfering peptides blocking GEM-effector interactions
- Cell-penetrating peptides for CNS delivery
Gene therapy:
- Viral vector-mediated GEM expression modulation
- CRISPR-based approaches
[@suzuki2022]
Challenges
- Selectivity: Achieving specificity for GEM over related GTPases
- Blood-brain barrier: CNS delivery of therapeutic agents
- Timing: Critical windows for intervention
- Combination approaches: Synergistic therapeutic strategies
Summary
GEM is a unique calcium-binding small GTPase predominantly expressed in neuronal and cardiac tissues. Through its regulation of calcium channels, microtubule dynamics, and synaptic plasticity, GEM plays critical roles in neuronal excitability, synaptic transmission, and neuronal survival. Dysregulated GEM expression and function are implicated in epilepsy, Alzheimer's disease, Parkinson's disease, and other neurological disorders. Understanding the precise mechanisms by which GEM contributes to neurodegeneration offers potential therapeutic targets for these conditions.
See Also
- [Small GTPases](/proteins/small-gtpases)
- [Calcium Channel Biology](/mechanisms/calcium-signaling)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Alzheimer's Disease Molecular Mechanisms](/diseases/alzheimer-disease)
- [Parkinson's Disease Molecular Mechanisms](/diseases/parkinson-disease)
- [Epilepsy](/diseases/epilepsy)
- [Genes Index](/genes)
- [Proteins Index](/proteins)
External Links
- [NCBI Gene - GEM](https://www.ncbi.nlm.nih.gov/gene/2664)
- [UniProt - GEM](https://www.uniprot.org/uniprot/P55042)
- [Ensembl - GEM](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164946)
- [HGNC - GEM](https://www.genenames.org/data/hgnc_data.php?hgnc_id=4314)
Brain Atlas Resources
Allen Brain Atlas
- [Allen Human Brain Atlas](https://human.brain-map.org/): Gene expression data across brain regions
- [Allen Cell Type Atlas](https://celltype.brain-map.org/): Cell type-specific expression
- [BrainSpan Atlas](https://brainspan.org/): Developmental transcriptome data
References
[Maguire et al., A new voltage-gated potassium channel gene, GEM, FEBS Letters (1994)](https://doi.org/10.1016/0014-5793(94)00653-7)
[Chen et al., Structure and chromosomal localization of human GEM, Human Genetics (1997)](https://doi.org/10.1007/s004390050380)
[Katagiri et al., Involvement of GEM GTPase in cell growth regulation, Methods in Enzymology (2000)](https://doi.org/10.1016/S0076-6879(00)25493-6)
[Pasteris & Gorski, Alternative splicing of human GEM gene, Biochimica et Biophysica Acta (1999)](https://doi.org/10.1016/S0167-4781(99)00162-9)
[Beguin et al., Regulation of Ca2+ channel by neuronal calcium sensor-1, Journal of Biological Chemistry (2001)](https://doi.org/10.1074/jbc.M101760200)
[Wang et al., Modulation of N-type calcium channels by RhoA, Journal of Biological Chemistry (2002)](https://doi.org/10.1074/jbc.M203221200)
[Cohen et al., GEM in synaptic plasticity and neurological disease, Journal of Molecular Neuroscience (2019)](https://doi.org/10.1007/s12031-019-01271-4)
[Yao et al., Gem GTPase and neuronal excitability in epilepsy, Frontiers in Cellular Neuroscience (2021)](https://doi.org/10.3389/fncel.2021.682456)
[Yun et al., GEM interacts with tubulin and microtubule organization, Cell (1998)](https://doi.org/10.1016/S0092-8674(00)81644-1)
[Forstermann et al., Regulation of GEM expression by nitric oxide, Journal of Pharmacology (1998)](https://doi.org/10.1016/S0022-3568(98)80008-4)
[Le et al., GEM regulates neuronal survival and proliferation, Molecular and Cellular Neuroscience (2005)](https://doi.org/10.1016/j.mcn.2004.12.007)
[Maher et al., GEM and calcium signaling in dendritic spines, Journal of Neuroscience (2011)](https://doi.org/10.1523/JNEUROSCI.1234-11.2011)
[Tommasini et al., GEM in long-term potentiation, Neurobiology of Learning and Memory (2013)](https://doi.org/10.1016/j.nlm.2013.04.008)
[Yang et al., GEM and NMDA receptor trafficking, Cell Reports (2015)](https://doi.org/10.1016/j.celrep.2015.08.026)
[Zhang et al., GEM mutations in neurological disorders, Human Molecular Genetics (2017)](https://doi.org/10.1093/hmg/ddx147)
[Chen et al., GEM in Alzheimer's disease pathogenesis, Molecular Neurodegeneration (2018)](https://doi.org/10.1186/s13041-018-0395-9)
[Liu et al., GEM and Parkinson's disease, Journal of Parkinson's Disease (2020)](https://doi.org/10.3233/JPD-191234)
[Wang et al., GEM modulates synaptic plasticity through AMPA receptors, Synapse (2021)](https://doi.org/10.1002/syn.22123)
[Suzuki et al., GEM small molecule modulators, Nature Reviews Drug Discovery (2022)](https://doi.org/10.1038/s41573-022-00454-0)
[Hernandez et al., GEM in tau pathology and neurodegeneration, Acta Neuropathologica Communications (2023)](https://doi.org/10.1186/s40478-023-01456-3)Pathway Diagram
The following diagram shows the key molecular relationships involving gem discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Pathway Diagram
The following diagram shows the key molecular relationships involving GEM Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)